MarginsXMarginsX
Home › Markets › Health Care › VCRE

Vicore Pharma Holding AB (VCRE)

VCRE trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$10.16
-1.93% on the day
Market cap
$2.9B
Mid cap
Revenue
New registrant: no annual report filed under this company yet
Net income
New registrant: no annual report filed under this company yet

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerVCRE on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountrySweden
IPO yearNot reported by the screener
SEC CIK0002124403

Financials

New registrant: no annual report filed under this company yet.

Warning signs

Cash runway
no XBRL financials
Share count, 1 year
No year-earlier count
Going-concern doubt
No recent 10-K, 10-Q or 20-F
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernNo recent periodic reportNone on EDGAR
Cash and burnno XBRL financialsNone on EDGAR
Shares outstandingNo cover-page share count in XBRLNone on EDGAR
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorErnst & Young AB, Stockholm, SwedenPCAOB Form AP 2026-06-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30
SEC reportingThe company has never filed a periodic report with the SEC, so its SEC industry code was never reviewed against one.None on EDGAR

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Key SEC documents

The SEC filing list did not load in time for this page. It is on SEC EDGAR and in the full dossier.

Price moves

WindowReturn
1 week-0.4%
1 month+15.8%
3 months-15.8%
Year to dateNot enough price history
1 yearNot enough price history
From 52-week high-36.2%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
IDYAIDEAYA Biosciences Inc.$30.36-4.62%$2.9B
TLXTelix Pharmaceuticals Limited$8.92-3.36%$3.0B
XERSXeris Biopharma Holdings Inc.$16.70+0.24%$3.1B
XNCRXencor Inc.$35.40-4.56%$2.7B
ZLABZai Lab Limited$23.47-4.59%$2.6B
MBXMBX Biosciences Inc.$53.12-5.04%$2.6B
LEGNLegend Biotech Corporation$15.99-8.63%$3.1B
DYNDyne Therapeutics Inc.$16.70-2.68%$3.1B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier